Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract PR015: Discovery of LY4050784 (FHD-909), a Selective BRM (SMARCA2) ATPase Inhibitor for the Treatment of BRG1(SMARCA4) Mutant Cancers
Janice Y. Lee,Nathan Brooks,Brandon Antonakos, Bryan Perria, Candace Langan,Bonita D. Jones,Robert Stephen Flack,Zhifang Li, David Terry,Ross Wallace,Robert Bondi, Gereint Sis,Ronee Baracani,Maralee McVean, Gabrielle Kolakowski, Dayo Osimboni,Kevin Wilson
Molecular Cancer Therapeuticsno. 6_Supplement (2024)
Cited0Views0Bibtex
0
0
Discovery of LY4050784 (FHD-909), a Selective BRM (SMARCA2) ATPase Inhibitor for the Treatment of BRG1(SMARCA4) Mutant Cancers
Janice Y. Lee,Nathan Brooks,Brandon Antonakos, Bryan Perria, Candace Langan,Bonita D. Jones,Robert Stephen Flack, Zhifang Li, David Terry,Ross Wallace,Robert Bondi, Gereint Sis,Ronee Baracani,Maralee McVean, Gabrielle Kolakowski, Dayo Osimboni,Kevin Wilson
MOLECULAR CANCER THERAPEUTICSno. 6 (2024)
Cited0Views0Bibtex
0
0
Discovery of Selective BRM (SMARCA2) ATPase Inhibitors for the Treatment of BRG1 (SMARCA4) Mutant Cancers
Janice Y. Lee,Nathan Brooks,Brandon Antonakos, Bryan Perria, Candace Langan,Bonita D. Jones,Robert Stephen Flack,Zhifang Li, David Terry,Ross Wallace,Robert Bondi, Gereint Sis,Ronee Baracani,Maralee McVean, Gabrielle Kolakowski, Dayo Osimboni,Kevin Wilson
Cancer Researchno. 6_Supplement (2024): 3230-3230
Cited1Views0Bibtex
1
0
Load More
Author Statistics

#Papers: 17

#Citation: 602

H-Index: 5

G-Index: 10

Sociability: 5

Diversity: 2

Activity: 1

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn